Does

Circle Pharma develops advanced biopharmaceutical treatments, specifically CID-165 for ER-positive breast cancer, targeting the cancer treatment market.

Founded

2012

Headcount

66

Type

Privately Held

Industry

Biotechnology Research

Via Alexandria from FullEnrich: founded, headcount, type, industry

• [ LEAD ]The Column Group
• [ PART ]ELEli Lilly and Company
• [ PART ]ECEuclidean Capital
• [ PART ]Nextech Invest
• [ PART ]RA Capital Management

• Roundup: Sling Therapeutics Closes $123 Million Series C Financing, Circle Pharma Announces $92.5 Million Series E Financing | PharmExecpharmexec.com · Sep 16 · Series D+
• Circle Pharma Announces $92.5 Million Series E Financing to Advance First-in-class Cyclin D1 Program into Clinical Developmentbusinesswire.com · Sep 15 · Series D+